SCIENTIFIC-PRACTICAL JOURNAL

| укр | рус |

 

 


No2(4) 2021

Back to the issue


DOI 10.37219/2528-8253-2021-2-45

Al Hariri MJ, Koshel IV, Popovych VI
Clinical and immunological efficiency of bacteriophage in technique of delayed prescribing of antibiotics in patients with acute post-viral rhinosinusitis
Al Hariri Mahmoud Jоmaa
Ivano-Frankivsk National Medical University
Department of Otorhinolaryngology – Head and Neck Surgery
Graduate student
E-mail: alhariri.mahmoud75@gmail.com
ORCID ID: https://orcid.org/0000-0002-8669-7026

Koshel Ivanna V.
Ivano-Frankivsk National Medical University
Associate Professor at the Department of Internal Medicine and Family Medicine
Doctor of Medical Sciences
ORCID ID: https://orcid.org/0000-0002-5466-4537

Popovych Vasyl I.
Ivano-Frankivsk National Medical University
Head of Department of Otorhinolaryngology – Head and Neck Surgery
Doctor of Medical Sciences, Professor
E-mail: popovychvasyl@gmail.com
ORCID ID: https://orcid.org/0000-0002-2898-8474

Abstract

Topicality: Acute Rhinosinusitis can be characterised as acute bacterial rhinosinusitis just in about 0,5 - 2% of the number of viral one and only such patients need prescription of antibiotics. At the same time, antibacterial therapy is prescribed in from 54% to 77% cases of Acute Rhinosinusitis. To reduce the number of unreasonable prescriptions, the strategy of delayed prescribing of antibioticsis the forward-looking one.
Aim: to evaluate the level of IgА and sIgA in patients with post-viral RS and estimate the clinical and immunological efficiency of polyvalent bacteriophage in technique of delayed prescribing of antibiotics in comparison with the patients receiving standard APVRS therapy.
Material and methods: 155 adult patients with acute post-viral RS participated in the trial who were given either standard therapy or polyvalent bacteriophage in addition to the standard therapy. In conjunction with the treatment, the IgА and sIgA levels were evaluated and their comparison with clinical dynamics was undertaken.
Evaluation criteria: decrease in intensity of disease symptoms evaluated in accordance with MSS scale system during each visit in comparison with the 1st visit, antibiotic prescribing frequency, dynamics of changes of serum and secretory IgА levels.
Results and discussion: The use of polyvalent bacteriophagein addition to the standard therapy of acute post-viral rhinosinusitisas a part of technique of delayed prescribing of antibiotics ensures clinically significant, faster dynamics of regression of typical clinical symptoms of post-viral rhinosinusitis: rhinorrhea, nasal congestion and post-nasal drip in comparison with the control group (p<0.05). Positive dynamics of clinical symptomatology is followed by the fair increase of IgА and sIgA levels (p<0.005), in comparison with the level before treatment and the control group. The statistically significant difference between the control group and the intervention one in IgА and sIgA indicators is associated with fairly higher (by 20%) rate of prescribing of antibiotics in the control group.
Conclusion: polyvalent bacteriophage is a safe and effective medication for additional treatment of acute post-viral rhinosinusitis intended to improve indicators of systemic and local immunity and reduce the rate of use of antibiotics. The inclusion of the medication into the treatment regimen could be recommended to the patients as a part of technique of delayed prescribing of antibiotics.

Keywords

acute rhinosinusitis, polyvalent bacteriophage, delayed antibiotic therapy, IgА, sIgA.


Reference

  1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi: 10.4193/ Rhin20.600
  2. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Kumar KA, Kramper M, et al. Clinical practice guideline (update): Adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(4):598-609. doi: 10.1177/0194599815574247.
  3. Jaume F, Quintó L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ open 2018 Jan 31;8(1):e018788.
    doi: 10.1136/bmjopen-2017-018788.
  4. Hoffmans R, Wagemakers A, van Hellings P, Fokkens W. Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment. PLoS One. 2018;13(2): e0192330. doi: 10.1371/journal.pone.0192330.
  5. Eloy P, Poirrier AL, De Dorlodot C, Van Zele T, Watelet JB, Bertrand B. Actual concepts in rhinosinusitis: a review of clinical presentations inflammatory pathways, cytokine profiles, remodeling, and management. Curr Allergy Asthma Rep.
    2011;11(2):146-62. doi: 10.1007/s11882-011-0180-0.
  6. Tan KS, Yan Y, Ong HH, Chow VTK, Shi L, Wang D-Y. Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):24. doi: 10.1007/s11882-017-0693-2.
  7. Braciale TJ, Sun J, Kim TS. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol. 2012;12(4):295-305. doi: 10.1038/nri3166.
  8. Tan KS, Yan Y, Koh WLH, Li L, Choi H, Tran T, et al. Comparative Transcriptomic and Metagenomic Analyses of Influenza Virus-Infected Nasal Epithelial Cells From Multiple Individuals Reveal Specific Nasal-Initiated Signatures. Front Microbiol. 2018;9:2685. doi: 10.3389/fmicb.2018.02685.
  9. Knipe DM, Howley PM, Griffin DE, Eds. Fields Virology. 4th Ed. Philadelphia: Lippincott Williams & Wilkins; 2001. Lamb RA, Krug RM. Orthomyxoviridae: The Viruses and Their Replication; p. 1487-1531.
  10. Sugrue RJ. Interactions between respiratory syncytial virus and the host cell: opportunities for antivirus strategies? Expert Rev Mol Med. 2006;8(21):1-17. doi: 10.1017/S1462399406000081.
  11. Kolesnikova L, Heck S, Matrosovich T, Klenk H-D, Becker S, Matrosovich M. Influenza virus budding from the tips of cellular microvilli in differentiated human airway epithelial cells. J Gen Virol. 2013;94(Pt 5):971-6. doi: 10.1099/vir.0.049239-0.
  12. Yan Y, Tan KS, Li C, et al. Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro. J Allergy Clin Immunol. 2016; 138(1):276-281.e15. doi: 10.1016/j.jaci.2015.11.016.
  13. Yan Y, Gordon WM, Wang D-Y. Nasal epithelial repair and remodeling in physical injury, infection, and inflammatory diseases. Curr Opin Otolaryngol Head Neck Surg. 2013;21(3):263-70. doi: 10.1097/MOO.0b013e32835f80a0.
  14. Wang DY, Li Y, Yan Y, Li C, Shi L. Upper Airway Stem Cells: Understanding the Nose and Role for Future Cell Therapy. Curr Allergy Asthma Rep. 2015;15(1):490. doi: 10.1007/s11882-014-0490-0.
  15. Watelet JB, Van Zele T, Gjomarkaj M, Canonica GW, Dahlen S-E, Fokkens W, et al. Tissue remodelling in upper airways: where is the link with lower airway remodeling? Allergy. 2006;61(11): 1249-58.
    doi: 10.1111/j.1398-9995.2006.01226.x.
  16. Clay CC, Reader JR, Gerriets JE, Wang TT, Har- rod KS, Miller LA. Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection. J Virol. 2014;88(13):7412-25. doi: 10.1128/JVI.00188-14.
  17. Wang Z, Wan Y, Qiu C, Quiñones-Parra S, Zhu Z, Liyen L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells. Nat Commun. 201513;6:6833. doi: 10.1038/ncomms7833.
  18. Hoggard M, Wagner Mackenzie B, Jain R, Taylor MW, Biswas K, Douglas RG. Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease. Clin Microbiol Rev. 2017;30(1):321-348.
    doi: 10.1128/CMR.00060-16.
  19. Drannik G, Kurchenko A, Drannik А. [Mucosal immune system, physiological microflora and probiotics]. Кiev: Polygraph plus; 2009. 141 p. [In Russian].
  20. Pilette C, Durham S. Vaerman J, Sibille Y. Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A? Proc Am Thorac Soc. 2004;1(2):125-35. doi: 10.1513/pats.2306032.
  21. Mikhailenko HV, Kolyada TI, Vdovichenko NI. Changes in the level of secretory immunoglobulin A in patients with inflammatory processes of URT of various etiologies. Visnyk problem biolohiï i medytsyny. 2013;2 (1):137-9. [In Russian].
  22. Unified clinical protocol of primary, secondary (specilised) and tertiary (highly-specialized) medical assistance “Acute Rhinosinusitis” Available from: https://dec.gov.ua/wp-content/uploads/ images/dodatki/2016_85_GRS/ 2016_85_YKPMD
    _GRS.pdf. [In Ukrainian].
 

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»